Tuberculous Pericarditis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-08-21
Clinical Trial Update: High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis [Phase 2]
Phase 2 trial comparing high-dose versus standard-dose rifampicin for effusive tuberculous pericarditis; currently recruiting.